Literature DB >> 7969721

Involvement of free oxygen radicals in beta-amyloidosis: an hypothesis.

A L Friedlich1, L L Butcher.   

Abstract

Compelling evidence suggests that cerebral deposition of aggregating beta-amyloid protein may trigger the neurodegenerative cascades of Alzheimer's disease, Down syndrome, and, to a lesser degree, normal aging. We propose further that free oxygen radicals are critically involved in beta-amyloidosis. Apart from the established role of free radicals in other amyloidoses, our proposal is consistent with a large number of findings. Among these are (a) the salient relationship of Alzheimer's disease with aging and the increase in free oxygen radical liberation with advancing age; (b) biochemical and analytic epidemiologic evidence that free radical formation is increased in the disorder; (c) preliminary evidence that quenching free radicals slows the clinical progression of Alzheimer's disease; (d) the early and invariable beta-amyloid accumulation in trisomy 21, a syndrome associated with elevated free radical activity and with concomitant high levels of beta-amyloid precursor protein; (e) other factors that may be associated with increased liberation of free oxygen radicals and deposition of beta-amyloid protein. Possible mechanisms by which free radicals might modulate beta-amyloidosis are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969721     DOI: 10.1016/0197-4580(94)90076-0

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  13 in total

Review 1.  The toxicity in vitro of beta-amyloid protein.

Authors:  L L Iversen; R J Mortishire-Smith; S J Pollack; M S Shearman
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

2.  Down's syndrome and the links with Alzheimer's disease.

Authors:  A J Holland; C Oliver
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-08       Impact factor: 10.154

Review 3.  Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease.

Authors:  C Glabe
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

4.  Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses.

Authors:  S M Yatin; M Aksenova; M Aksenov; W R Markesbery; T Aulick; D A Butterfield
Journal:  J Mol Neurosci       Date:  1998-12       Impact factor: 3.444

Review 5.  Oxidative Stress in Alzheimer's Disease: Should We Keep Trying Antioxidant Therapies?

Authors:  Michelli Erica Souza Ferreira; Amanda Soares de Vasconcelos; Thyago da Costa Vilhena; Thiago Leite da Silva; Aline da Silva Barbosa; Antonio Rafael Quadros Gomes; Maria Fani Dolabela; Sandro Percário
Journal:  Cell Mol Neurobiol       Date:  2015-01-24       Impact factor: 5.046

6.  The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.

Authors:  G P Lim; T Chu; F Yang; W Beech; S A Frautschy; G M Cole
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

7.  Cholinergic stimulation of AP-1 and NF kappa B transcription factors is differentially sensitive to oxidative stress in SH-SY5Y neuroblastoma: relationship to phosphoinositide hydrolysis.

Authors:  X Li; L Song; R S Jope
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

Review 8.  What can rodent models tell us about cognitive decline in Alzheimer's disease?

Authors:  Sabrina Davis; Serge Laroche
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

9.  beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger.

Authors:  A J Bruce; B Malfroy; M Baudry
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

10.  Inflammation and the pathophysiology of Alzheimer's disease.

Authors:  M M Greer
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.